Toll Free: 1-888-928-9744
Toll Free: 1-888-928-9744
Published: Jul, 2017 | Pages:
143 | Publisher: Global Markets Direct
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)
Alopecia - Pipeline Review, H2 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Alopecia - Pipeline Review, H2 2017, provides an overview of the Alopecia (Dermatology) pipeline landscape. Alopecia is the partial or complete loss of hair especially on the scalp either in patches, on the entire head or over the entire body. Thinning hair is the most obvious symptom. The predisposing factors include allergies, irritants, toxins, burns, injuries, and infections. Report Highlights Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Alopecia - Pipeline Review, H2 2017, provides comprehensive information on the therapeutics under development for Alopecia (Dermatology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. The Alopecia (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Alopecia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical and Discovery stages are 1, 1, 12, 5, 1, 19 and 9 respectively. Similarly, the Universities portfolio in Phase III and Discovery stages comprises 1 and 1 molecules, respectively. Alopecia (Dermatology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis. Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data. Scope - The pipeline guide provides a snapshot of the global therapeutic landscape of Alopecia (Dermatology). - The pipeline guide reviews pipeline therapeutics for Alopecia (Dermatology) by companies and universities/research institutes based on information derived from company and industry-specific sources. - The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages. - The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities. - The pipeline guide reviews key companies involved in Alopecia (Dermatology) therapeutics and enlists all their major and minor projects. - The pipeline guide evaluates Alopecia (Dermatology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type. - The pipeline guide encapsulates all the dormant and discontinued pipeline projects. - The pipeline guide reviews latest news related to pipeline therapeutics for Alopecia (Dermatology) Reasons to buy - Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies. - Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage. - Find and recognize significant and varied types of therapeutics under development for Alopecia (Dermatology). - Classify potential new clients or partners in the target demographic. - Develop tactical initiatives by understanding the focus areas of leading companies. - Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics. - Formulate corrective measures for pipeline projects by understanding Alopecia (Dermatology) pipeline depth and focus of Indication therapeutics. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope. - Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Table of Contents
Table of Contents 2 List of Tables 4 List of Figures 5 Introduction 6 Global Markets Direct Report Coverage 6 Alopecia - Overview 7 Alopecia - Therapeutics Development 8 Pipeline Overview 8 Pipeline by Companies 9 Pipeline by Universities/Institutes 12 Products under Development by Companies 13 Products under Development by Universities/Institutes 16 Alopecia - Therapeutics Assessment 17 Assessment by Target 17 Assessment by Mechanism of Action 20 Assessment by Route of Administration 23 Assessment by Molecule Type 25 Alopecia - Companies Involved in Therapeutics Development 27 Aclaris Therapeutics Inc 27 Allergan Plc 27 Almirall SA 28 AndroScience Corp 28 Berg LLC 29 BiologicsMD Inc 29 BirchBioMed Inc 30 Brickell Biotech Inc 30 Bristol-Myers Squibb Company 31 Cassiopea SpA 31 Daewoong Pharmaceutical Co Ltd 32 Dong-A Socio Holdings Co Ltd 32 Handok Inc 33 Histogen Inc 33 Hyundai Pharmaceutical Co Ltd 34 Incyte Corp 34 Kuhnil Pharmaceutical Co Ltd 35 Lee's Pharmaceutical Holdings Ltd 35 LEO Pharma A/S 36 Medivir AB 36 NovaLead Pharma Pvt Ltd 37 Panacea Biotec Ltd 37 Pfizer Inc 38 Quark Pharmaceuticals Inc 38 RXi Pharmaceuticals Corp 39 Samumed LLC 39 Switch Biotech LLC 40 Taisho Pharmaceutical Holdings Co Ltd 40 Tigo GmbH 41 viDA Therapeutics Inc 41 Alopecia - Drug Profiles 42 (cyclosporine A + minoxidil + RT-175) - Drug Profile 42 abatacept - Drug Profile 43 AI-001 - Drug Profile 51 Antibodies to Inhibit Heparanase for Alopecia, Colitis, Diabetic Nephropathy, Transplantation and Oncology - Drug Profile 52 Antisense Oligonucleotide to Inhibit Androgen Receptor for Alopecia - Drug Profile 53 ASCJ-9 - Drug Profile 54 ATI-50001 - Drug Profile 56 ATI-50002 - Drug Profile 57 ATI-50003 - Drug Profile 58 BBI-5000 - Drug Profile 59 BMD-1141 - Drug Profile 60 BMD-1341 - Drug Profile 61 BMD-2341 - Drug Profile 62 BQ-A - Drug Profile 63 BRM-421 - Drug Profile 64 calcitriol - Drug Profile 65 CB-0301 - Drug Profile 66 DHL-HisZnNa - Drug Profile 69 finasteride - Drug Profile 70 finasteride - Drug Profile 71 FOL-005 - Drug Profile 72 HGEN-001 - Drug Profile 75 HL-5945 - Drug Profile 77 HTB-005 - Drug Profile 78 interferon beta-1b - Drug Profile 79 KI-1104 - Drug Profile 80 KI-1105 - Drug Profile 81 LEO-124249 - Drug Profile 82 minoxidil - Drug Profile 83 NLP-602 - Drug Profile 84 OLX-104 - Drug Profile 85 PF-06651600 - Drug Profile 86 PF-06700841 - Drug Profile 87 QPAL-1 - Drug Profile 89 QPAL-2 - Drug Profile 90 RBAG-010 - Drug Profile 91 Recombinant Proteins to Agonize EGFR for Alopecia and Arthritis - Drug Profile 92 Recombinant Proteins to Antagonize IFN-Gamma Receptor 1 for Alopecia Areata and Graft Arteriosclerosis - Drug Profile 93 remetinostat - Drug Profile 94 ruxolitinib phosphate - Drug Profile 97 Samcyprone - Drug Profile 112 setipiprant - Drug Profile 114 SM-04554 - Drug Profile 116 Small Molecule for Androgenic Alopecia - Drug Profile 119 Small Molecules to Inhibit JAK for Alopecia Areata, Androgenetic Alopecia and Dermatological Disorders - Drug Profile 120 Synthetic Peptide for Alopecia - Drug Profile 121 TP-0427736 - Drug Profile 122 TS-133 - Drug Profile 123 VTI-1000 Series - Drug Profile 124 ZK-003 - Drug Profile 125 Alopecia - Dormant Projects 126 Alopecia - Discontinued Products 128 Alopecia - Product Development Milestones 129 Featured News & Press Releases 129 Appendix 138 Methodology 138 Coverage 138 Secondary Research 138 Primary Research 138 Expert Panel Validation 138 Contact Us 138 Disclaimer 139
List of Tables
Number of Products under Development for Alopecia, H2 2017 Number of Products under Development by Companies, H2 2017 Number of Products under Development by Companies, H2 2017 (Contd..1), H2 2017 Number of Products under Development by Universities/Institutes, H2 2017 Products under Development by Companies, H2 2017 Products under Development by Companies, H2 2017 (Contd..1), H2 2017 Products under Development by Companies, H2 2017 (Contd..2), H2 2017 Products under Development by Universities/Institutes, H2 2017 Number of Products by Stage and Target, H2 2017 Number of Products by Stage and Target, H2 2017 (Contd..1), H2 2017 Number of Products by Stage and Mechanism of Action, H2 2017 Number of Products by Stage and Mechanism of Action, H2 2017 (Contd..1), H2 2017 Number of Products by Stage and Route of Administration, H2 2017 Number of Products by Stage and Molecule Type, H2 2017 Alopecia - Pipeline by Aclaris Therapeutics Inc, H2 2017 Alopecia - Pipeline by Allergan Plc, H2 2017 Alopecia - Pipeline by Almirall SA, H2 2017 Alopecia - Pipeline by AndroScience Corp, H2 2017 Alopecia - Pipeline by Berg LLC, H2 2017 Alopecia - Pipeline by BiologicsMD Inc, H2 2017 Alopecia - Pipeline by BirchBioMed Inc, H2 2017 Alopecia - Pipeline by Brickell Biotech Inc, H2 2017 Alopecia - Pipeline by Bristol-Myers Squibb Company, H2 2017 Alopecia - Pipeline by Cassiopea SpA, H2 2017 Alopecia - Pipeline by Daewoong Pharmaceutical Co Ltd, H2 2017 Alopecia - Pipeline by Dong-A Socio Holdings Co Ltd, H2 2017 Alopecia - Pipeline by Handok Inc, H2 2017 Alopecia - Pipeline by Histogen Inc, H2 2017 Alopecia - Pipeline by Hyundai Pharmaceutical Co Ltd, H2 2017 Alopecia - Pipeline by Incyte Corp, H2 2017 Alopecia - Pipeline by Kuhnil Pharmaceutical Co Ltd, H2 2017 Alopecia - Pipeline by Lee's Pharmaceutical Holdings Ltd, H2 2017 Alopecia - Pipeline by LEO Pharma A/S, H2 2017 Alopecia - Pipeline by Medivir AB, H2 2017 Alopecia - Pipeline by NovaLead Pharma Pvt Ltd, H2 2017 Alopecia - Pipeline by Panacea Biotec Ltd, H2 2017 Alopecia - Pipeline by Pfizer Inc, H2 2017 Alopecia - Pipeline by Quark Pharmaceuticals Inc, H2 2017 Alopecia - Pipeline by RXi Pharmaceuticals Corp, H2 2017 Alopecia - Pipeline by Samumed LLC, H2 2017 Alopecia - Pipeline by Switch Biotech LLC, H2 2017 Alopecia - Pipeline by Taisho Pharmaceutical Holdings Co Ltd, H2 2017 Alopecia - Pipeline by Tigo GmbH, H2 2017 Alopecia - Pipeline by viDA Therapeutics Inc, H2 2017 Alopecia - Dormant Projects, H2 2017 Alopecia - Dormant Projects, H2 2017 (Contd..1), H2 2017 Alopecia - Discontinued Products, H2 2017
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.
